Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Rejuvenate Bio Receives $4M Grant from California Institute for Regenerative Medicine (CIRM) for RJB-0402 Development
Sep 01, 2026•4 days ago
San DiegoBiotechnologyHealth CareDescription
Rejuvenate Bio has received a $4M grant from the California Institute for Regenerative Medicine (CIRM) to complete IND-enabling activities for the development of RJB-0402, a novel gene therapy for the treatment of desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM).
Related People
Suggested for you
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months
Rejuvenate Bio signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.